KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
87 hedge funds and large institutions have $280M invested in Kindred Biosciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 22
Holders
87
Holding in Top 10
–
Calls
$4.06M
Puts
$830K
Top Buyers
| 1 | +$25M | |
| 2 | +$16.6M | |
| 3 | +$6.62M | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$6.56M |
| 5 |
Morgan Stanley
New York
|
+$5.74M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$17.4M | |
| 3 | -$8.16M | |
| 4 |
AI
Ariel Investments
Chicago,
Illinois
|
-$5.76M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.74M |